Antara Capital’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-67,167
Closed -$299K 153
2022
Q2
$299K Buy
67,167
+16,667
+33% +$74.2K 0.01% 122
2022
Q1
$448K Hold
50,500
0.01% 130
2021
Q4
$445K Hold
50,500
0.02% 111
2021
Q3
$576K Buy
50,500
+8,833
+21% +$101K 0.04% 85
2021
Q2
$700K Buy
+41,667
New +$700K 0.04% 93